These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8277090)

  • 21. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
    Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
    J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ECG repolarization waves: their genesis and clinical implications.
    Hlaing T; DiMino T; Kowey PR; Yan GX
    Ann Noninvasive Electrocardiol; 2005 Apr; 10(2):211-23. PubMed ID: 15842434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
    Morganroth J
    Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsades de Pointes: 50 Years Later, Can We See It Coming?
    Davis AM
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003850. PubMed ID: 26839387
    [No Abstract]   [Full Text] [Related]  

  • 27. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pauses after burst pacing provoke afterdepolarizations and torsades de pointes in a patient with long QT syndrome.
    Kirchhof P; Zellerhoff S; Mönnig G; Schulze-Bahr E
    Heart Rhythm; 2004 Dec; 1(6):720-3. PubMed ID: 15851245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of humps on monophasic action potentials and ST-T alternans in a patient with Romano-Ward syndrome.
    Sakurada H; Tejima T; Hiyoshi Y; Motomiya T; Hiraoka M
    Pacing Clin Electrophysiol; 1991 Oct; 14(10):1485-91. PubMed ID: 1721131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.
    Brachmann J; Scherlag BJ; Rosenshtraukh LV; Lazzara R
    Circulation; 1983 Oct; 68(4):846-56. PubMed ID: 6616779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early afterdepolarizations and arrhythmogenesis. Experimental and clinical aspects.
    el-Sherif N
    Arch Mal Coeur Vaiss; 1991 Feb; 84(2):227-34. PubMed ID: 1708655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and ionic basis for T-wave alternans under long-QT conditions.
    Shimizu W; Antzelevitch C
    Circulation; 1999 Mar; 99(11):1499-507. PubMed ID: 10086976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of early afterdepolarization in familial long QTU syndrome and torsade de pointes.
    Zhou JT; Zheng LR; Liu WY
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2164-8. PubMed ID: 1279619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs.
    Singh BN; Wadhani N
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S85-97. PubMed ID: 15378133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic basis of drug-induced arrhythmias.
    Vos MA; Paulussen AD
    Ann Med; 2004; 36 Suppl 1():35-40. PubMed ID: 15176422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical repolarization gradients determine the induction of reentry-based torsades de pointes arrhythmia in models of long QT syndrome.
    Rivaud MR; Bayer JD; Cluitmans M; van der Waal J; Bear LR; Boukens BJ; Belterman C; Gottlieb L; Vaillant F; Abell E; Dubois R; Meijborg VMF; Coronel R
    Heart Rhythm; 2021 Feb; 18(2):278-287. PubMed ID: 33031961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.
    Lu HR; Gallacher DJ; Yan GX
    J Pharmacol Toxicol Methods; 2016; 81():151-60. PubMed ID: 27374776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.